Ángel Cores

520 total citations
19 papers, 390 citations indexed

About

Ángel Cores is a scholar working on Molecular Biology, Organic Chemistry and Pharmacology. According to data from OpenAlex, Ángel Cores has authored 19 papers receiving a total of 390 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Molecular Biology, 9 papers in Organic Chemistry and 6 papers in Pharmacology. Recurrent topics in Ángel Cores's work include Cholinesterase and Neurodegenerative Diseases (6 papers), Genomics, phytochemicals, and oxidative stress (5 papers) and Chemical Synthesis and Analysis (3 papers). Ángel Cores is often cited by papers focused on Cholinesterase and Neurodegenerative Diseases (6 papers), Genomics, phytochemicals, and oxidative stress (5 papers) and Chemical Synthesis and Analysis (3 papers). Ángel Cores collaborates with scholars based in Spain, United Kingdom and Italy. Ángel Cores's co-authors include J. Carlos Menéndez, Mercedes Villacampa, Rafael León, Patrycja Michalska, Giammarco Tenti, M. Teresa Ramos, M. Antonia Martín, Pilar López‐Alvarado, Verónica Estévez and Manuela G. López and has published in prestigious journals such as SHILAP Revista de lepidopterología, Scientific Reports and Journal of Medicinal Chemistry.

In The Last Decade

Ángel Cores

18 papers receiving 381 citations

Peers

Countries citing papers authored by Ángel Cores

Since Specialization

Citations

This map shows the geographic impact of Ángel Cores's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ángel Cores with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ángel Cores more than expected).

Fields of papers citing papers by Ángel Cores

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ángel Cores. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ángel Cores. The network helps show where Ángel Cores may publish in the future.

Co-authorship network of co-authors of Ángel Cores

This figure shows the co-authorship network connecting the top 25 collaborators of Ángel Cores. A scholar is included among the top collaborators of Ángel Cores based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ángel Cores. Ángel Cores is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

19 of 19 papers shown

#	Work	Indexed citations
1	Network-Based Drug Optimization toward the Treatment of Parkinson’s Disease: NRF2, MAO-B, Oxidative Stress, and Chronic Neuroinflammation 2025 ·Journal of Medicinal Chemistry ·Pablo Duarte, (unknown), (unknown), Ángel Cores, (unknown), Antonio Cuadrado, J. Carlos Menéndez, Rafael León	1
2	Quinones as Neuroprotective Agents 2023 ·Antioxidants ·Ángel Cores, (unknown), (unknown), Mercedes Villacampa, J. Carlos Menéndez	47
3	Quinolinetrione-tacrine hybrids as multi-target-directed ligands against Alzheimer's disease 2023 ·Bioorganic & Medicinal Chemistry ·Elisa Uliassi, Christian Bergamini, Nicola Rizzardi, Marina Naldi, Ángel Cores, Manuela Bartolini, J. Carlos Menéndez, María Laura Bolognesi	12
4	Bifunctional carbazole derivatives for simultaneous therapy and fluorescence imaging in prion disease murine cell models 2022 ·European Journal of Medicinal Chemistry ·Matteo Staderini, Silvia Vanni, (unknown), Gabriele Giachin, (unknown), (unknown), (unknown), Edoardo Bistaffa, Fabio Moda, Daniel I. Pérez, Ana Martı́nez, M. Antonia Martín, (unknown), Ángel Cores, (unknown), Robert Kammerer, J. Carlos Menéndez, Giuseppe Legname, María Laura Bolognesi	11
5	Enantioselective Synthesis and Pharmacological Evaluation of Aza-CGP37157–Lipoic Acid Hybrids for the Treatment of Alzheimer’s Disease 2022 ·Antioxidants ·Ángel Cores, Patrycja Michalska, (unknown), (unknown), Clara Gómez, Mercedes Villacampa, J. Carlos Menéndez, Rafael León	6
6	Multicomponent Reactions for the Synthesis of Active Pharmaceutical Ingredients 2022 ·Pharmaceuticals ·Ángel Cores, (unknown), (unknown), J. Carlos Menéndez	41
7	Fluorescence Sensors Based on Hydroxycarbazole for the Determination of Neurodegeneration-Related Halide Anions 2022 ·Biosensors ·Víctor González‐Ruiz, Ángel Cores, (unknown), Vellaisamy Sridharan, Mercedes Villacampa, M. Antonia Martín, Ana I. Olives, J. Carlos Menéndez	5
8	Emerging targets in drug discovery against neurodegenerative diseases: Control of synapsis disfunction by the RhoA/ROCK pathway 2021 ·European Journal of Medicinal Chemistry ·(unknown), Ángel Cores, Pilar López‐Alvarado, J. Carlos Menéndez	25
9	(E)-3-((2-Fluorophenyl)(hydroxy)methylene)imidazo[1,2-a]pyridin-2(3H)-one 2021 ·SHILAP Revista de lepidopterología ·Giammarco Tenti, Ángel Cores, M. Teresa Ramos, J. Carlos Menéndez	2
10	Curcumin-Piperlongumine Hybrids with a Multitarget Profile Elicit Neuroprotection in In Vitro Models of Oxidative Stress and Hyperphosphorylation 2021 ·Antioxidants ·Ángel Cores, (unknown), (unknown), (unknown), Pablo Duarte, Mercedes Villacampa, Paloma Bermejo‐Bescós, Sagrario Martín‐Aragón, Rafael León, J. Carlos Menéndez	11
11	Bisavenathramide Analogues as Nrf2 Inductors and Neuroprotectors in In Vitro Models of Oxidative Stress and Hyperphosphorylation 2021 ·Antioxidants ·Ángel Cores, (unknown), Patrycja Michalska, Pablo Duarte, Ana I. Olives, M. Antonia Martín, Mercedes Villacampa, Rafael León, J. Carlos Menéndez	19
12	Enhanced Stability and Bioactivity of Natural Anticancer Topoisomerase I Inhibitors through Cyclodextrin Complexation 2021 ·Pharmaceutics ·Víctor González‐Ruiz, Ángel Cores, (unknown), (unknown), Víctor Cervera-Carrascón, Patrycja Michalska, Ana I. Olives, Rafael León, M. Antonia Martín, J. Carlos Menéndez	22
13	NRF2 Regulation Processes as a Source of Potential Drug Targets against Neurodegenerative Diseases 2020 ·Biomolecules ·Ángel Cores, (unknown), Mercedes Villacampa, Rafael León, J. Carlos Menéndez	67
14	Synthesis of 1,4-Diazepanes and Benzo[b][1,4]diazepines by a Domino Process Involving theIn SituGeneration of an Aza-Nazarov Reagent 2020 ·The Journal of Organic Chemistry ·Swarupananda Maiti, Marco Leonardi, Ángel Cores, Giammarco Tenti, M. Teresa Ramos, Mercedes Villacampa, J. Carlos Menéndez	1
15	Aza‐CGP37157‐lipoic hybrids designed as novel Nrf2‐inducers and antioxidants exert neuroprotection against oxidative stress and show neuroinflammation inhibitory properties 2019 ·Drug Development Research ·Patrycja Michalska, Giammarco Tenti, (unknown), Ángel Cores, M. Teresa Ramos, Antonio G. Garcı́a, J. Carlos Menéndez, Rafael León	9
16	Discovery of the first dual GSK3β inhibitor/Nrf2 inducer. A new multitarget therapeutic strategy for Alzheimer’s disease 2017 ·Scientific Reports ·Isabel Gameiro‐Ros, Patrycja Michalska, Giammarco Tenti, Ángel Cores, Izaskun Buendía, Ana I. Rojo, Nikolaos Georgakopoulos, Jesús M. Hernández‐Guijo, M. Teresa Ramos, Geoffrey Wells, Manuela G. López, Antonio Cuadrado, J. Carlos Menéndez, Rafael León	70
17	Three-component access to 2-pyrrolin-5-ones and their use in target-oriented and diversity-oriented synthesis 2016 ·RSC Advances ·Ángel Cores, Verónica Estévez, Mercedes Villacampa, J. Carlos Menéndez	24
18	Structure‐Based Design of New KSP‐Eg5 Inhibitors Assisted by a Targeted Multicomponent Reaction 2014 ·ChemBioChem ·(unknown), Miguel A. Prado, Hugo Gutiérrez‐de‐Terán, Ángel Cores, Jhonny Azuaje, Silvia Novío, Marı́a J. Núñez, Belén Fernández‐García, Eddy Sotelo, Xerardo García‐Mera, Pedro S. Lazo, Manuel Freire‐Garabal, Alberto Coelho	6
19	Multicomponent Reactions in Antimitotic Drug Discovery 2014 ·Current Topics in Medicinal Chemistry ·Ángel Cores, (unknown), Alberto Coelho	11

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact